Sub-specialty:

• Lung, Head and Neck, Breast and Gastrointestinal Cancers
  
  

Medical Conditions Treated:

• Lymphomas
• Nasopharyngeal carcinoma,
• Hepatocellular carcinoma
• Other cancer conditions
  
  

Languages:

English, Mandarin, Cantonese, Hokkien, Bahasa Melayu, Bahasa Indonesia

Education:

MBBS (Hons), MRCP (UK), FAMS (Medical Oncology), FRCP (UK)

Professional Profile:

Dr Chan graduated with the distinction of honours from National University of Singapore (NUS) School of Medicine in 2000. He was further trained in internal medicine and obtained the Member of the Royal College of Physicians; MRCP (UK) in 2004. He received his medical oncology specialist training with the National University Cancer Institute of Singapore. He finished his final year of fellowship in the USA at the University of California, Los Angeles (UCLA) and Cedars- Sinai Medical Centre.

He honed his medical oncology clinical expertise at UCLA and Cedars-Sinai with Dr Ronald Natale (lung cancer), Dr Michael Lill (lymphoma), Dr Charles Forscher (sarcoma) and Dr Albert Lai (neuro-oncology) under an endowment grant from the National University Hospital of Singapore. He also pursued research in the laboratory of world-famous haematologist-oncologist Professor Phillip Koeffler under a National Medical Research Council Overseas Fellowship. Upon his return, he was a consultant in medical oncology at the National University Cancer Institute Singapore and director of undergraduate education (medical oncology) at the National University of Singapore.

He was also actively involved in cancer research at the Cancer Science Institute Singapore and held a new investigator grant from the NMRC on triple negative breast cancer. He was the first in South Asia to use the PD-1 inhibitor immunotherapy drug (Pembrolizumab) in clinical practice in October 2014.